Not Tagged
Not Tagged
['lcsm,(-blcsm)', 'sclc']
targeting #tigit in #es-#sclc does not appear to offer additional therapeutic benefit. disappointing, but important to present negative results as well as positive! #lcsm #asco22 
Co-Founder, @EGFRResisters LC Patient Group; writer for https://t.co/W6HLnN0ibZ; lc advocate/survivor; dx stage IV 2013
https://t.co/2UwibVmlPs